The restructuring forms part of Burjeel 2.0, the group’s transformation programme designed to align operations and establish clearer accountability for clinical outcomes, patient experience and financial performance.
The initiative aims to help individuals understand how cardiovascular health, sleep, metabolism and physical recovery influence ageing and long-term health.
Trellis Health’s expansion comes as Dubai plans for population growth and increased demand for healthcare infrastructure.
Lixudebart targets Claudin-1, a protein associated with tissue fibrosis, the process through which excessive scar tissue accumulates and damages organs.
The agreements cover cardiovascular disease, diabetes and oncology, with provisions for licensing, technology transfer and local manufacturing partnerships.
Under the agreement, the companies will identify and implement targeted applications of agentic AI, an AI systems designed to perform tasks and execute workflows with varying degrees of autonomy.
The partnership aims to simplify access to health services and encourage people to take a more proactive approach to their physical and mental wellbeing.
The agreement was signed at the Precision Health Partnerships in Singapore event and witnessed by Ong Ye Kung, Singapore’s Minister for Health and Coordinating Minister for Social Policies.
The deal gives Kyowa Kirin access to Knight’s pan-American commercial infrastructure while allowing Knight to add a targeted oncology therapy to its portfolio.
Through the partnership, startups will gain opportunities to work with Unilabs on technology integration, proof-of-concept projects, and commercial partnerships.